Skip to search.
 FTSE 100 Down 1.89%

More On UCBJY

Quotes

Derivatives

  • Warrants
  • Investment Products

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

UCB S.A. (UCBJY)

-Other OTC
40.56 0.00(0.00%) 5 Feb 19:45
|Pre-Market : NaN
Prev Close:40.56
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:N/A
Beta:0.501621
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:34.10 - 46.25
Volume:0
Avg Vol (3m):200
Market Cap:15.31b
P/E (ttm):41.47
EPS (ttm):0.98
Div & Yield:0.59 (1.46%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for UCBJY at this time.

Comparison

Symbol% ChgMkt Cap
UCBJY 0.00%15.31b
PFEDown 0.90%177.61b
JNJUp 0.40%279.29b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):3.72
Ex-Dividend Date:30-Apr-15

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

UCB S.A., a biopharmaceutical company, focuses on the discovery and development of medicines and solutions for people living with severe diseases of the immune system or of the central nervous system in Belgium and internationally. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback